Last updated September 24, 2026

DimpHealth

Developing devices that make emergency blood sampling and IV care safer

Medical DevicesEmergency CareProvider Workflow

Blood samples taken during emergencies are often rejected because red blood cells break down before they reach the laboratory. Each rejected sample means another draw, a delayed result and more clinical time, and most laboratory errors happen in the .

DimpHealth develops low-cost devices for emergency and prehospital care, starting with the TClamp for safer blood sampling, alongside intravenous supports designed for ambulances and treatment rooms.

Key Investor Signals

Won Spain's national patient-safety Silver award

The T-Clamp protocol received a Silver award in Spain's national patient-safety awards, run by the Ministry of Health, recognising its contribution to safer blood sampling.

T-Clamp adopted by Jaén medicalized ambulances

Medicalized emergency ambulances in Jaén adopted the T-Clamp for routine use, giving the device a live deployment inside a public emergency service.

Public emergency-service pilot expanded beyond initial units

A pilot within the public emergency service expanded beyond the units where it started, with the device used in additional teams.

Other Positive Signals

  • The Andalusian Health Service licensed the T-Clamp through , the regional biomedical research institute.
  • Won the 2025 Premios Emprendemos Granada and was the province's best-rated entrant.
  • Recognised as a FIBAO–ibs.GRANADA spin-off through the public innovation network.
  • DimpHealth joined the 2024 AcexHealth accelerator cohort and presented at its 2025 Investor Day.
  • Spain's commercial register granted DimpHealth emerging-company status under Law 28/2022 in May 2025.

Team

Nicolás Benítez Muñoz

CEO and Co-founder

  • Works as an emergency nurse in the Andalusian public health system, where the need behind the T-Clamp was identified.
  • Co-inventor of the T-Clamp, the utility model licensed by the Andalusian Health Service.
  • Leads DimpHealth's commercial relationships with public emergency services and hospitals.

Pedro Jesús Milla Ortega

Co-founder, R&D

  • Leads research and development work on DimpHealth's device portfolio.
  • Focuses on translating clinical workflow problems into manufacturable device designs.

Ángela Jiménez García

Co-founder, R&D

  • Holds a PhD and leads DimpHealth's research work alongside product development.
  • Principal investigator of the TClamp clinical pilot running from 2024 to 2027.

Beatriz García Jiménez

Co-founder, Finance

  • Leads DimpHealth's finance function, covering funding, grants and public programme reporting.

Product

DimpHealth develops low-cost devices for emergency and prehospital care, built around the way clinicians already work. Its portfolio covers blood-sampling safety and intravenous support.

TClamp

A 15 g polypropylene rack holding six tubes that clips onto an IV line, designed for at least 5,000 cycles. It standardises how samples are handled during emergency draws.

Dimpus IV Bag

An emergency backpack with an integrated IV pole, so infusion can be set up without a separate stand during prehospital care.

MagIV Pole

A magnetic intravenous support that attaches to metal surfaces, giving teams a fast fixing point inside ambulances and treatment rooms.

Market Overview

Blood samples taken during emergencies are frequently rejected because red blood cells break down before analysis. Each rejected sample means a repeat draw, a delayed result and additional clinical time, and the preanalytical phase accounts for the majority of laboratory errors.

Emergency and prehospital care is a large equipment market where public services buy consumables and supports at scale. DimpHealth targets that setting with low-cost devices designed around existing IV and sampling workflows rather than new equipment.

Hemolysis rate in emergency samples
17.2%

Reported share of emergency department blood samples affected by .

Laboratory errors from the preanalytical phase
46–68%

Published range for the share of laboratory errors arising before analysis.

Emergency department visits
33.6M

Annual emergency department visits recorded in the reference market.

Emergency medical equipment market
$9.13B

Estimated market value for emergency medical equipment.

Comparable Outcomes

Emergency devices

Physio-Control

Acquired by Stryker for $1.28B

Physio-Control manufactured defibrillators and emergency response equipment used by hospitals and prehospital services. acquired the company for $1.28B, adding it to its emergency care portfolio.

Acute care equipment

ZOLL Medical

Acquired by Asahi Kasei for $2.21B

Medical developed resuscitation and acute critical care devices and software used in emergency medical services and hospitals. Asahi Kasei acquired ZOLL for $2.21B.

Interested in More Startups Like DimpHealth?

Get a curated pipeline of healthcare and life sciences startups aligned with your investment thesis.

Get Deal Flow

Sources

This profile was built from public company materials, ecosystem sources, market references, and professional profiles.

Get the DealBio Pulse

Weekly insights on health and longevity startups, standout founders, key markets, and notable exits.

You can unsubscribe at any time.